These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32781184)

  • 61. [Axillary hyperhidrosis: successful treatment with botulinum toxin A].
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Botulinum toxin for axillary hyperhidrosis.
    de Almeida AR; Montagner S
    Dermatol Clin; 2014 Oct; 32(4):495-504. PubMed ID: 25152343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cryoanalgesia with dichlorotetrafluoroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhidrosis.
    Baumann L; Frankel S; Welsh E; Halem M
    Dermatol Surg; 2003 Oct; 29(10):1057-9; discussion 1060. PubMed ID: 12974705
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T3 versus T4 thoracoscopic sympathectomy for palmar hyperhidrosis: a meta-analysis and systematic review.
    Zhang W; Wei Y; Jiang H; Xu J; Yu D
    J Surg Res; 2017 Oct; 218():124-131. PubMed ID: 28985838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of axillary and palmar hyperhidrosis with botulinum toxin.
    Goldman A
    Aesthetic Plast Surg; 2000; 24(4):280-2. PubMed ID: 10954791
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Botulinum toxin for treatment of craniofacial hyperhidrosis.
    Böger A; Herath H; Rompel R; Ferbert A
    J Neurol; 2000 Nov; 247(11):857-61. PubMed ID: 11151418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyperhidrosis Substantially Reduces Quality of Life in Children: A Retrospective Study Describing Symptoms, Consequences and Treatment with Botulinum Toxin.
    Mirkovic SE; Rystedt A; Balling M; Swartling C
    Acta Derm Venereol; 2018 Jan; 98(1):103-107. PubMed ID: 28761964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Limited endoscopic thoracic sympathetic block for hyperhidrosis of the upper limb: reduction of compensatory sweating by clipping T4.
    Neumayer C; Zacherl J; Holak G; Függer R; Jakesz R; Herbst F; Bischof G
    Surg Endosc; 2004 Jan; 18(1):152-6. PubMed ID: 14625754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selection of safe parameters for jet injection of botulinum toxin in palmar hyperhidrosis.
    Nantel-Battista M; Vadeboncoeur S; Benohanian A
    Aesthet Surg J; 2013 Feb; 33(2):295-7. PubMed ID: 23388650
    [No Abstract]   [Full Text] [Related]  

  • 72. Severe compensatory hyperhidrosis following thoracic sympathectomy successfully treated with low doses of botulinum toxin A.
    Santana-Rodríguez N; Clavo B; Calatayud-Gastardi J; García-Castellano JM; Ponce-González MA; Olmo-Quintana V; Llontop P; Alvarez-Prats A; Yordi NA; Ruíz-Caballero JA
    J Dermatolog Treat; 2012 Dec; 23(6):457-60. PubMed ID: 21756156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
    Patel AT; Lew MF; Dashtipour K; Isaacson S; Hauser RA; Ondo W; Maisonobe P; Wietek S; Rubin B; Brashear A
    PLoS One; 2021; 16(2):e0245827. PubMed ID: 33524060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Hyperhidrosis: treatment, results, problems].
    Motus IY; Bazhenov AV
    Khirurgiia (Mosk); 2021; (7):12-17. PubMed ID: 34270188
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
    Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term outcomes after endothoracic sympathetic block at the T4 ganglion for upper limb hyperhidrosis.
    Panhofer P; Gleiss A; Eilenberg WH; Jakesz R; Bischof G; Neumayer C
    Br J Surg; 2013 Oct; 100(11):1471-7. PubMed ID: 24037567
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
    Rompel R; Scholz S
    J Eur Acad Dermatol Venereol; 2001 May; 15(3):207-11. PubMed ID: 11683282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
    Vlahovic TC; Dunn SP; Blau JC; Gauthier C
    J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Iyer S
    Dermatol Surg; 2002 Sep; 28(9):822-7. PubMed ID: 12269876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.